BackFirst Wave BioPharma Overview

First Wave BioPharma Net Tangible Assets

First Wave BioPharma's net tangible assets is $20M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$19.67M
↓ 412.30% YoYΔ $25.97M vs prior year quarter

Peer trimmed avg / median

Loading

First Wave BioPharma Net Tangible Assets History

Loading

First Wave BioPharma vs. peers: Net Tangible Assets Comparison

Loading

First Wave BioPharma Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

First Wave BioPharma (FWBI) FAQ

As of the most recent data (June 2026), FWBI shows a net tangible assets of $20M. That compares with $-6.3M in the prior-year period — up 412.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FWBI's net tangible assets is now $20M (was $-6.3M) — a 412.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether First Wave BioPharma is outperforming or lagging.

Tracking FWBI's net tangible assets over time shows whether First Wave BioPharma is scaling, shrinking, or reshaping that part of the business. The current reading is $20M That compares with $-6.3M in the prior-year period — up 412.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has First Wave BioPharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $20M) with ownership activity and broader fundamentals.

First Wave BioPharma's net tangible assets is $20M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.